— Know what they know.
Not Investment Advice

YMAB NASDAQ

Y-mAbs Therapeutics, Inc.
1W: +0.3% 1M: +1.1% 3M: +74.3% 1Y: -35.0% 3Y: -47.2% 5Y: -79.7%
$8.61
Last traded 2025-09-16 — delisted
NASDAQ · Healthcare · Biotechnology · $391.2M mcap · 34M float · 2.62% daily turnover · Short 55% of daily vol
Oct Typical
☁️
Cloudy
+0.0% YTD avg
2026 Now
☁️
Cloudy
Tracking typical
20yr Avg YTD
—
2026 YTD
—
Typical Vol
108%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+1.6%
Midterm
⛈️
-26.5%
43% win 78% vol
Feb
20yr
⛈️
+2.9%
Midterm
⛈️
-23.3%
29% win 69% vol
Mar
20yr
💨
+5.9%
Midterm
⛈️
-26.3%
43% win 116% vol
Apr
20yr
⛈️
+6.6%
Midterm
⛈️
-48.3%
29% win 72% vol
May
20yr
💨
+13.2%
Midterm
⛈️
-27.3%
71% win 101% vol
Jun
20yr
💨
+12.9%
Midterm
⛈️
-11.9%
43% win 62% vol
Jul
20yr
⛈️
+7.2%
Midterm
⛈️
-7.0%
29% win 57% vol
Aug
20yr
💨
+22.5%
Midterm
⛈️
-7.7%
71% win 148% vol
Sep
20yr
⛈️
+19.9%
Midterm
⛈️
-17.2%
38% win 58% vol
Oct
20yr
⛈️
+18.4%
Midterm
⛈️
-79.3%
43% win 108% vol
Nov
20yr
💨
+16.6%
Midterm
⛈️
-74.3%
71% win 78% vol
Dec
20yr
⛈️
-7.0%
Midterm
⛈️
-4.6%
29% win 65% vol
Seasonality (20yr)

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms